Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
Coherus BioSciences, Inc. announces the release of its fourth quarter and full year 2023 financial results on March 13, 2024. The management team will host a conference call and webcast to discuss the results and provide a business update. Investors can access the webcast and related materials on the Coherus website.
03/05/2024 - 04:01 PM
REDWOOD CITY, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that its fourth quarter and full year 2023 financial results will be released after market close on Wednesday, March 13, 2024. Starting at 5:00 pm ET on March 13, 2024, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
A replay of the webcast will be available on http://investors.coherus.com following the conclusion of the live conference call.
Conference Call Information
When: Wednesday, March 13, 2024, starting at 5:00 p.m. Eastern Time
To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https://register.vevent.com/register/BI41e6b8f8ab024eefafe43493f6fd0cdf
Webcast: https://edge.media-server.com/mmc/p/7c7bss7i
The press release with the fourth quarter and full year 2023 financial results and related materials will be available at https://investors.coherus.com prior to the start of the conference call.
A live and archived webcast will be available on the “Investors” section of the Coherus website at https://investors.coherus.com/events-presentations.
Please dial-in 15 minutes early to ensure a timely connection to the call.
Coherus Contact Information IR@coherus.com
When will Coherus BioSciences release its fourth quarter and full year 2023 financial results?
Coherus BioSciences will release its fourth quarter and full year 2023 financial results after market close on Wednesday, March 13, 2024.
How can investors access the conference call hosted by Coherus BioSciences?
Investors can access the conference call by pre-registering through the provided link to receive dial-in information and a personal PIN for the live call.
Where can investors find the webcast and related materials for Coherus BioSciences' financial results?
Investors can find the webcast and related materials on the 'Investors' section of the Coherus website at https://investors.coherus.com/events-presentations.
CHRS Rankings
#5124 Ranked by Stock Gains
CHRS Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Redwood City
About CHRS
coherus biosciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. founded in 2010, coherus is a late-stage biologics platform company focused on the global biosimilar market. headquartered in the san francisco bay area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, our goal is to become a global leader in the biosimilar market by leveraging our team's collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. our commercialization partnerships include global pharmaceutical companies in europe, asia and latin america. biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and exp
